PeptideDB

1H-pyrazole 288-13-1

1H-pyrazole 288-13-1

CAS No.: 288-13-1

1H-pyrazole is an endogenously produced metabolite.
Sales Email:peptidedb@qq.com

This product is for research use only, not for human use. We do not sell to patients.

1H-pyrazole is an endogenously produced metabolite.

Physicochemical Properties


Molecular Formula C3H4N2
Molecular Weight 68.08
Exact Mass 68.037
CAS # 288-13-1
Related CAS # 105809-46-9
PubChem CID 1048
Appearance Off-white to light brown solid powder
Density 1.1±0.1 g/cm3
Boiling Point 187.0±9.0 °C at 760 mmHg
Melting Point 67-70 °C(lit.)
Flash Point 87.5±11.7 °C
Vapour Pressure 0.9±0.3 mmHg at 25°C
Index of Refraction 1.528
LogP 0.32
Hydrogen Bond Donor Count 1
Hydrogen Bond Acceptor Count 1
Rotatable Bond Count 0
Heavy Atom Count 5
Complexity 28.1
Defined Atom Stereocenter Count 0
InChi Key WTKZEGDFNFYCGP-UHFFFAOYSA-N
InChi Code

InChI=1S/C3H4N2/c1-2-4-5-3-1/h1-3H,(H,4,5)
Chemical Name

1H-pyrazole
HS Tariff Code 2934.99.9001
Storage

Powder-20°C 3 years

4°C 2 years

In solvent -80°C 6 months

-20°C 1 month

Shipping Condition Room temperature (This product is stable at ambient temperature for a few days during ordinary shipping and time spent in Customs)

Biological Activity


Additional Infomation 1H-pyrazole is the 1H-tautomer of pyrazole. It is a conjugate base of a pyrazolium. It is a conjugate acid of a pyrazol-1-ide. It is a tautomer of a 3H-pyrazole and a 4H-pyrazole.
Pyrazole has been reported in Glycyrrhiza glabra with data available.
Pyrazole is a heterocyclic organic compound characterized by a ring structure composed of three carbon atoms and two nitrogen atoms in adjacent positions, with the molecular formula C3H4N2.

Solubility Data


Solubility (In Vitro) DMSO: 100 mg/mL (1468.86 mM)
Solubility (In Vivo) Solubility in Formulation 1: ≥ 2.5 mg/mL (36.72 mM) (saturation unknown) in 10% DMSO + 40% PEG300 + 5% Tween80 + 45% Saline (add these co-solvents sequentially from left to right, and one by one), clear solution.
For example, if 1 mL of working solution is to be prepared, you can add 100 μL of 25.0 mg/mL clear DMSO stock solution to 400 μL PEG300 and mix evenly; then add 50 μL Tween-80 to the above solution and mix evenly; then add 450 μL normal saline to adjust the volume to 1 mL.
Preparation of saline: Dissolve 0.9 g of sodium chloride in 100 mL ddH₂ O to obtain a clear solution.

Solubility in Formulation 2: ≥ 2.5 mg/mL (36.72 mM) (saturation unknown) in 10% DMSO + 90% (20% SBE-β-CD in Saline) (add these co-solvents sequentially from left to right, and one by one), clear solution.
For example, if 1 mL of working solution is to be prepared, you can add 100 μL of 25.0 mg/mL clear DMSO stock solution to 900 μL of 20% SBE-β-CD physiological saline solution and mix evenly.
Preparation of 20% SBE-β-CD in Saline (4°C,1 week): Dissolve 2 g SBE-β-CD in 10 mL saline to obtain a clear solution.

Solubility in Formulation 3: ≥ 2.5 mg/mL (36.72 mM) (saturation unknown) in 10% DMSO + 90% Corn Oil (add these co-solvents sequentially from left to right, and one by one), clear solution.
For example, if 1 mL of working solution is to be prepared, you can add 100 μL of 25.0 mg/mL clear DMSO stock solution to 900 μL of corn oil and mix evenly.

 (Please use freshly prepared in vivo formulations for optimal results.)
Preparing Stock Solutions 1 mg 5 mg 10 mg
1 mM 14.6886 mL 73.4430 mL 146.8860 mL
5 mM 2.9377 mL 14.6886 mL 29.3772 mL
10 mM 1.4689 mL 7.3443 mL 14.6886 mL
*Note: Please select an appropriate solvent for the preparation of stock solution based on your experiment needs. For most products, DMSO can be used for preparing stock solutions (e.g. 5 mM, 10 mM, or 20 mM concentration); some products with high aqueous solubility may be dissolved in water directly. Solubility information is available at the above Solubility Data section. Once the stock solution is prepared, aliquot it to routine usage volumes and store at -20°C or -80°C. Avoid repeated freeze and thaw cycles.